NCT00504582View on ClinicalTrials.gov

Fibrin Melanoma Axillary Node Study in Patients With Melanoma

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

May 15, 2002

Primary Completion Date

April 9, 2020

Study Completion Date

April 9, 2020

Conditions
Melanoma
Interventions
DRUG

Fibrin Sealant

Tisseel applied externally to the dissected axillary area.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT00504582 - Fibrin Melanoma Axillary Node Study in Patients With Melanoma | Biotech Hunter | Biotech Hunter